[go: up one dir, main page]

MX2014013095A - Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc. - Google Patents

Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc.

Info

Publication number
MX2014013095A
MX2014013095A MX2014013095A MX2014013095A MX2014013095A MX 2014013095 A MX2014013095 A MX 2014013095A MX 2014013095 A MX2014013095 A MX 2014013095A MX 2014013095 A MX2014013095 A MX 2014013095A MX 2014013095 A MX2014013095 A MX 2014013095A
Authority
MX
Mexico
Prior art keywords
dosage form
pharmaceutical dosage
thermoformed
tamper
containing zinc
Prior art date
Application number
MX2014013095A
Other languages
English (en)
Other versions
MX357783B (es
Inventor
Lutz Barnscheid
Eric Galia
Anja Geissler
Sebastian Schwier
Jana Pätz
Julia Baronsky-Probst
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2014013095A publication Critical patent/MX2014013095A/es
Publication of MX357783B publication Critical patent/MX357783B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con una forma de dosificación farmacéutica termoconformada, resistente al uso indebido que comprende: a) un ingrediente farmacológicamente activo; b) un óxido de polialquileno que tiene un promedio en peso de peso molecular de más de 200,000 g/mol; y c) un componente de zinc, en donde el contenido del componente de zinc es de por lo menos 1 ppm, en relación al peso total de la forma de dosificación farmacéutica.
MX2014013095A 2012-05-11 2013-05-10 Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc. MX357783B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12003743 2012-05-11
PCT/EP2013/059728 WO2013167735A1 (en) 2012-05-11 2013-05-10 Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc

Publications (2)

Publication Number Publication Date
MX2014013095A true MX2014013095A (es) 2014-12-08
MX357783B MX357783B (es) 2018-07-25

Family

ID=48407572

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013095A MX357783B (es) 2012-05-11 2013-05-10 Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc.

Country Status (21)

Country Link
EP (1) EP2846835B1 (es)
JP (2) JP2015516406A (es)
CN (1) CN104428002B (es)
AU (1) AU2013257943B2 (es)
BR (1) BR112014026768A2 (es)
CA (1) CA2870012A1 (es)
CY (1) CY1119637T1 (es)
DK (1) DK2846835T3 (es)
EA (1) EA029171B1 (es)
ES (1) ES2650945T3 (es)
HR (1) HRP20171718T1 (es)
HU (1) HUE035123T2 (es)
IL (1) IL234815A0 (es)
LT (1) LT2846835T (es)
MX (1) MX357783B (es)
NO (1) NO2846835T3 (es)
PL (1) PL2846835T3 (es)
PT (1) PT2846835T (es)
RS (1) RS56685B1 (es)
SI (1) SI2846835T1 (es)
WO (1) WO2013167735A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
AR077420A1 (es) 2009-07-22 2011-08-24 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
MX2012000317A (es) 2009-07-22 2012-02-08 Gruenenthal Gmbh Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
JP5933553B2 (ja) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング アニオン性ポリマーを含む不正使用抵抗性剤形
AR087359A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
SI2736495T1 (sl) 2011-07-29 2017-12-29 Gruenenthal Gmbh Tableta, odporna proti zlorabi, ki zagotavlja takojšnje sproščanje zdravila
EP2819656A1 (en) 2012-02-28 2015-01-07 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
TR201815502T4 (tr) 2012-04-18 2018-11-21 Gruenenthal Gmbh Kurcalama veya dirençli ve doz boşalımına dirençli farmasötik dozaj formu.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
HK1246173A1 (zh) 2015-04-24 2018-09-07 Grünenthal GmbH 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
AU2016251851A1 (en) 2015-04-24 2017-11-09 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles
CA2983640A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant fixed dose combination providing fast release of two drugs from different particles
US20160310486A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix
US11234974B2 (en) 2015-05-28 2022-02-01 Lumosa Therapeutics Co., Ltd. Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
US10183018B2 (en) 2015-05-28 2019-01-22 Lumosa Therapeutics Co., Ltd. Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
EP0239973A3 (en) 1986-03-31 1989-11-08 Union Carbide Corporation Catalyst and process for alkylene oxide polymerization
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US4667013A (en) 1986-05-02 1987-05-19 Union Carbide Corporation Process for alkylene oxide polymerization
JP3073054B2 (ja) * 1991-07-11 2000-08-07 住友精化株式会社 アルキレンオキシド重合体の製造方法
JP2002265592A (ja) 2001-03-07 2002-09-18 Sumitomo Seika Chem Co Ltd アルキレンオキシド重合体の製造方法
US7141250B2 (en) 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US20050019399A1 (en) 2001-09-21 2005-01-27 Gina Fischer Controlled release solid dispersions
JP4551089B2 (ja) 2001-10-29 2010-09-22 マサチューセッツ インスティテュート オブ テクノロジー 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
JP4939217B2 (ja) * 2003-08-06 2012-05-23 グリューネンタ−ル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 乱用防止剤形
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
DE10360792A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
EP1740156B8 (de) 2004-04-22 2012-07-11 Grünenthal GmbH Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
WO2005105036A1 (en) * 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
WO2006002884A1 (de) 2004-07-01 2006-01-12 Grünenthal GmbH Gegen missbrauch gesicherte, orale darreichtungsform
AR049839A1 (es) 2004-07-01 2006-09-06 Gruenenthal Gmbh Procedimiento para la produccion deuna forma farmaceutica solida, protegida frente al abuso
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
PL1786403T3 (pl) 2004-07-01 2013-10-31 Gruenenthal Gmbh Doustna postać dawki zabezpieczona przed nadużywaniem zawierająca (1R, 2R)-3-(3-dimetyloamino-1-etylo0-2-metylo-propylo)fenol
US20060177380A1 (en) 2004-11-24 2006-08-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2006133733A1 (en) * 2005-06-13 2006-12-21 Flamel Technologies Oral dosage form comprising an antimisuse system
EP2104493A2 (en) 2007-01-16 2009-09-30 Egalet A/S Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
RU2011123377A (ru) 2008-11-14 2012-12-20 Портола Фармасьютиклз, Инк. ТВЕРДАЯ КОМПОЗИЦИЯ ДЛЯ КОНТРОЛИРУЕМОГО ВЫСВОБОЖДЕНИЯ АКТИВНЫХ ИОНИЗИРУЕМЫХ АГЕНТОВ, ХАРАКТЕРИЗУЮЩИХСЯ НИЗКОЙ РАСТВОРИМОСТЬЮ В ВОДЕ ПРИ НИЗКИХ ЗНАЧЕНИЯХ pН, И СПОСОБЫ ЕЕ ПРИМЕНЕНИЯ
AR077420A1 (es) 2009-07-22 2011-08-24 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion

Also Published As

Publication number Publication date
BR112014026768A2 (pt) 2017-06-27
MX357783B (es) 2018-07-25
DK2846835T3 (en) 2017-12-04
ES2650945T3 (es) 2018-01-23
CA2870012A1 (en) 2013-11-14
HK1207978A1 (en) 2016-02-19
WO2013167735A1 (en) 2013-11-14
PT2846835T (pt) 2017-12-15
AU2013257943B2 (en) 2017-10-05
CN104428002B (zh) 2017-08-11
JP2015516406A (ja) 2015-06-11
EA201401240A1 (ru) 2015-04-30
EP2846835A1 (en) 2015-03-18
CY1119637T1 (el) 2018-04-04
EP2846835B1 (en) 2017-09-06
LT2846835T (lt) 2017-12-27
JP2018065810A (ja) 2018-04-26
IL234815A0 (en) 2014-12-31
CN104428002A (zh) 2015-03-18
RS56685B1 (sr) 2018-03-30
HRP20171718T1 (hr) 2017-12-29
PL2846835T3 (pl) 2018-02-28
HUE035123T2 (en) 2018-05-02
SI2846835T1 (en) 2018-01-31
NO2846835T3 (es) 2018-02-03
JP6541748B2 (ja) 2019-07-10
AU2013257943A1 (en) 2014-10-09
EA029171B1 (ru) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2014013095A (es) Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc.
MX2014005820A (es) Forma de dosis farmaceutica oral a prueba de manipulacion que comprende un agente antagonista y/o repelente opioide, oxido de polialquileno y un polimero anionico.
MX2015016112A (es) Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
CL2011002970A1 (es) Forma de dosificacion termoformada en forma de tableta con resistencia a la rotura de por lo menos 300 n que comprende un opioide, de 0,001 a 5,0% de un acido multicarboxilico, de 0,001 a 5,0% de un antioxidante y un oxido de polialquileno con peso molecular de por lo menos 200.000 g/mol; kit; y procedimiento para su produccion.
MX2013005478A (es) Compuestos heterociclicos condensados antivirales.
MX356421B (es) Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
MX2015016254A (es) Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
UA106634C2 (uk) Тверда фармацевтична дозована форма
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
UA105766C2 (uk) Фармацевтична композиція, яка містить сіль стронцію, вітамін d і циклодекстрин
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
MX2014009720A (es) Composiciones alcoholicas espumables y antimicrobianas.
WO2010111640A3 (en) Anti-influenza formulations and methods
MX2016003754A (es) Una composicion farmaceutica estable que contiene amlodipina y valsartan.
MX2014013851A (es) Composiciones farmaceuticas topicas que comprenden terbinafina y urea.
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
IN2014DN08870A (es)
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
MX360559B (es) Péptidos antimicrobianos, composiciones que los comprende y usos.
MY160904A (en) Piperazines as antimalarial agents
PH12015501428A1 (en) Antibacterial compounds

Legal Events

Date Code Title Description
FG Grant or registration